Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children

Overview

Journal Pediatr Infect Dis J

Specialty Pediatrics

Date 2021 Aug 12

PMID 34382616

Citations 8

Authors

Emilie P Buddingh

Ann C T M Vossen

Hildo J Lamb

Roel L F Van Der Palen

Danielle M C Brinkman

Affiliations

Soon will be listed here.

Abstract

Multisystem inflammatory syndrome in children is a rare, potentially life-threatening postinfectious complication in children after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It is currently unknown if multisystem inflammatory syndrome in children (MIS-C) can recur upon reinfection with SARS-CoV-2. Here, we report on a former MIS-C patient who was reinfected with SARS-CoV-2 without recurrence of MIS-C.

Citing Articles

Anti-SARS-CoV-2 Vaccination and PIMS-TS-Friends or Foe? Case Reports and Literature Review.

Opoka-Winiarska V, Morawska-Michalska I, Mertowska P, Gosik K, Kadziolka O, Grywalska E Vaccines (Basel). 2024; 12(3).

PMID: 38543912 PMC: 10975931. DOI: 10.3390/vaccines12030278.

Readmission reasons of pediatric patients diagnosed with multisystem inflammatory syndrome after discharge.

Cem E, Kiymet E, Boncuoglu E, Sahinkaya S, Yilmaz Celebi M, Gulderen M Arch Rheumatol. 2023; 38(2):315-321.

PMID: 37680520 PMC: 10481694. DOI: 10.46497/ArchRheumatol.2023.9605.

Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children.

Castaldo P, dAlanno G, Biserni G, Moratti M, Conti F, Fabi M Pathogens. 2023; 12(8).

PMID: 37623957 PMC: 10458149. DOI: 10.3390/pathogens12080997.

Comparison of the course of multisystem inflammatory syndrome in children during different pandemic waves.

Ptak K, Szymonska I, Olchawa-Czech A, Kukla K, Cisowska M, Kwinta P Eur J Pediatr. 2023; 182(4):1647-1656.

PMID: 36719477 PMC: 9887239. DOI: 10.1007/s00431-022-04790-4.

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children.

Chow E, Englund J Infect Dis Clin North Am. 2022; 36(2):435-479.

PMID: 35636909 PMC: 8806161. DOI: 10.1016/j.idc.2022.01.005.

References

Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y . Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015; 25(3):239-45. PMC: 4341001. DOI: 10.2188/jea.JE20140089. View

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P . Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-1608. PMC: 7204765. DOI: 10.1016/S0140-6736(20)31094-1. View

Cromer D, Juno J, Khoury D, Reynaldi A, Wheatley A, Kent S . Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol. 2021; 21(6):395-404. PMC: 8082486. DOI: 10.1038/s41577-021-00550-x. View

Vella L, Giles J, Baxter A, Oldridge D, Diorio C, Kuri-Cervantes L . Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol. 2021; 6(57. PMC: 8128303. DOI: 10.1126/sciimmunol.abf7570. View

Hoste L, Van Paemel R, Haerynck F . Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021; 180(7):2019-2034. PMC: 7890544. DOI: 10.1007/s00431-021-03993-5. View

Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K . Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020; 26:100527. PMC: 7473262. DOI: 10.1016/j.eclinm.2020.100527. View

Medaglia A, Siracusa L, Gioe C, Giordano S, Cascio A, Colomba C . Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital J Pediatr. 2021; 47(1):95. PMC: 8054252. DOI: 10.1186/s13052-021-01041-4. View

Blink M, Buddingh E, Filippini L, Brinkman D, Joosten S, Klein R . [COVID-19-associated hyperinflammatory state in a 15-year-old female patient]. Ned Tijdschr Geneeskd. 2020; 164. View

Jiang L, Tang K, Levin M, Irfan O, Morris S, Wilson K . COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020; 20(11):e276-e288. PMC: 7431129. DOI: 10.1016/S1473-3099(20)30651-4. View

10.

Ouldali N, Toubiana J, Antona D, Javouhey E, Madhi F, Lorrot M . Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. JAMA. 2021; 325(9):855-864. PMC: 7851757. DOI: 10.1001/jama.2021.0694. View

11.

Jhaveri S, Ahluwalia N, Kaushik S, Trachtman R, Kowalsky S, Aydin S . Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function following Multisystem Inflammatory Syndrome in Children. J Pediatr. 2020; 228:290-293.e1. PMC: 7403848. DOI: 10.1016/j.jpeds.2020.08.002. View

12.

Wang J, Kaperak C, Sato T, Sakuraba A . COVID-19 reinfection: a rapid systematic review of case reports and case series. J Investig Med. 2021; 69(6):1253-1255. DOI: 10.1136/jim-2021-001853. View

13.

Feldstein L, Tenforde M, Friedman K, Newhams M, Rose E, Dapul H . Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021; 325(11):1074-1087. PMC: 7905703. DOI: 10.1001/jama.2021.2091. View

14.

Abrams J, Oster M, Godfred-Cato S, Bryant B, Datta S, Campbell A . Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 2021; 5(5):323-331. PMC: 7943393. DOI: 10.1016/S2352-4642(21)00050-X. View